세계의 주사용 세포 독성약 시장 보고서(2025년)

Injectable Cytotoxic Drugs Global Market Report 2025

US $ 4,490 ￦ 6,482,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,370,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,257,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

주사용 세포 독성약 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.6%로 251억 1,000만 달러로 성장합니다. 예측 기간 중 바이오시밀러 세포독성 의약품의 사용 증가, 외래 및 재택 화학요법의 중요성, 주사제 암 치료제 파이프라인의 확대, 암 발병률 증가, 저렴한 암 치료제에 대한 수요 증가로 인해 성장세를 보일 것으로 예측됩니다. 이 기간 중 예상되는 주요 동향으로는 주사제 전달 기술의 발전, 독성을 최소화하는 혁신적인 제제법, 항체약물접합체 개발의 진전, 암 치료제 개발에 AI의 통합, 제약사 간 협력 관계 강화 등이 있습니다.

류마티스 관절염 유병률 증가는 향후 수년간 주사제 세포독성 의약품 시장의 성장을 촉진할 것으로 예측됩니다. 류마티스 관절염은 만성적인 관절 염증, 통증, 궁극적인 관절 손상을 특징으로 하는 만성 자가면역질환입니다. 류마티스 관절염 환자 수 증가는 주로 인구의 고령화에 기인하며, 고령화가 진행되면 류마티스 관절염을 유발하는 유전자 돌연변이 및 면역계 기능 장애의 위험이 증가하기 때문입니다. 주사용 세포독성 약물은 빠르게 분열하는 세포를 표적으로 삼아 과도한 면역반응을 억제함으로써 류마티스 관절염을 치료하여 질병의 진행을 늦추고 증상을 완화하는 역할을 합니다. 예를 들어 2024년 6월, 독립 법정기관인 호주 보건 복지 연구소는 류마티스 관절염으로 인해 1,322명이 사망했으며, 인구 10만 명당 5.1명이 사망하여 2022년 전체 사망자의 0.7%를 차지했다고 보고했습니다. 2023년에는 전체 질병 부담의 2.0%, 전체 근골격계 질환으로 인한 부담의 16%를 차지합니다. 따라서 류마티스 관절염 발생률 증가는 주사용 세포독성 의약품 시장의 성장을 가속하고 있습니다.

주사제 세포독성 의약품 시장의 주요 업체들은 제품 라인을 확장하고 시장 진입을 가속화하기 위해 규제 당국의 승인을 확보하는 데 주력하고 있습니다. 약사 승인은 의약품이 판매 및 처방되기 전에 보건 당국이 필요한 안전성, 유효성, 품질 기준을 충족하는지 확인하는 공식적인 허가입니다. 예를 들어 일본에 본사를 둔 제약사 아스텔라스제약은 2024년 3월 일본 후생노동성으로부터 CLDN18.2 양성 절제 불가능한 진행성 및 재발성 위암을 적응증으로 하는 VYLOY(졸베툭시맙)의 허가를 취득했습니다. 이번 승인은 VYLOY와 화학요법의 병용요법이 무진행 생존기간과 전체 생존기간을 유의하게 개선하는 것으로 나타난 임상 3상 시험(SPOTLIGHT 및 GLOW)에 의해 지원되었습니다. 환자의 적격성 여부는 종양 세포에서 CLDN18.2의 발현을 검출하는 동반 진단 검사를 통해 결정됩니다. 이 치료법은 전 세계에서 진단이 늦어지고 예후가 좋지 않은 위암의 중요한 미충족 수요를 충족시킬 수 있는 치료법입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 주사용 세포 독성약 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 주사용 세포 독성약 시장 : 성장률 분석
• 세계의 주사용 세포 독성약 시장 실적 : 규모와 성장, 2019-2024
• 세계의 주사용 세포 독성약 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계의 주사용 세포 독성약 : TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 주사용 세포 독성약 시장 : 약제 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 알킬화제
• 대사 길항제
• 식물 알칼로이드
• 항종양 항생제
• 백금계 화합물
• 세포 상해성 항생제
• 기타 약제 유형
• 세계의 주사용 세포 독성약 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정맥내(IV)
• 근육내(IM)
• 피하(SC)
• 세계의 주사용 세포 독성약 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 약국
• 전문 드러그스토어
• 세계의 주사용 세포 독성약 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 유방암
• 폐암
• 전립선암
• 대장암
• 난소암
• 림프종
• 백혈병
• 기타 용도
• 세계의 주사용 세포 독성약 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 종양학 클리닉
• 외래 수술 센터
• 조사·학술기관
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 알킬화제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Cyclophosphamide
• Ifosfamide
• Melphalan
• Busulfan
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 대사 길항 제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Methotrexate
• 5-Fluorouracil (5-FU)
• Cytarabine
• Gemcitabine
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 식물 알칼로이드(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Vincristine
• Vinblastine
• Paclitaxel
• Docetaxel
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 항종양 항생제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Doxorubicin
• Daunorubicin
• Epirubicin
• Bleomycin
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 백금계 화합물(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Cisplatin
• Carboplatin
• Oxaliplatin
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 세포 상해성 항생제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Mitomycin
• Actinomycin D
• Plicamycin
• 세계의 주사용 세포 독성약 시장 : 서브 세분화, 기타 약제 유형, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Irinotecan
• Etoposide
• Eribulin
• Trastuzumab Emtansine (ADC)
• Lutetium-177 Dotatate

제7장 지역별·국가별 분석

• 세계의 주사용 세포 독성약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 주사용 세포 독성약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 주사용 세포 독성약 시장 : 경쟁 구도
• 주사용 세포 독성약 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• Eli Lilly and Company
• Amgen Inc.
• Merck KGaA
• Baxter International Inc.
• Fresenius Kabi AG
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Jazz Pharmaceuticals plc
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals Inc.
• Zydus Lifesciences Ltd.
• NATCO Pharma Ltd.
• Accord Healthcare Ltd.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 주사용 세포 독성약 시장 2029 : 새로운 기회를 제공하는 국가
• 주사용 세포 독성약 시장 2029 : 새로운 기회를 제공하는 부문
• 주사용 세포 독성약 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁사 전략

제36장 부록

KSA

영문 목차

영문목차

Injectable cytotoxic drugs are medications delivered by injection that target and destroy rapidly dividing cancer cells. These drugs are primarily used in chemotherapy and function by disrupting the cell division process to halt tumor growth.

The primary types of injectable cytotoxic drugs include alkylating agents, antimetabolites, plant alkaloids, antitumor antibiotics, platinum-based compounds, cytotoxic antibiotics, and others. Alkylating agents function by binding alkyl groups to DNA, causing damage that inhibits cancer cell replication. These drugs can be administered through intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes and are supplied via hospital pharmacies, retail pharmacies, online pharmacies, and specialty drug stores. They are used to treat a variety of cancers, including breast, lung, prostate, colorectal, ovarian cancers, lymphoma, and leukemia. Key end users include hospitals, oncology clinics, ambulatory surgical centers, and research and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The injectable cytotoxic drugs market research report is one of a series of new reports from The Business Research Company that provides injectable cytotoxic drugs market statistics, including injectable cytotoxic drugs industry global market size, regional shares, competitors with an injectable cytotoxic drugs market share, detailed injectable cytotoxic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the injectable cytotoxic drugs industry. This injectable cytotoxic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable cytotoxic drugs market size has grown strongly in recent years. It will grow from $18.16 billion in 2024 to $19.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period was driven by greater adoption of combination chemotherapy treatments, increased healthcare expenditure, a growing number of cancer specialty clinics and treatment centers, more approvals of generic injectable cytotoxic drugs, and heightened awareness of early cancer detection.

The injectable cytotoxic drugs market size is expected to see strong growth in the next few years. It will grow to $25.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The projected growth during the forecast period is driven by the increasing use of biosimilar cytotoxic drugs, greater emphasis on outpatient and home-based chemotherapy, an expanding pipeline of injectable oncology drugs, rising cancer incidence, and growing demand for affordable cancer treatments. Key trends expected in this period include advancements in injectable drug delivery technologies, innovative formulation methods to minimize toxicity, progress in antibody-drug conjugate development, the integration of AI in oncology drug discovery, and increased collaboration among pharmaceutical companies.

The rising incidence of rheumatoid arthritis is expected to drive the growth of the injectable cytotoxic drugs market in the coming years. Rheumatoid arthritis is a chronic autoimmune disorder marked by ongoing joint inflammation, pain, and eventual joint damage. The increase in rheumatoid arthritis cases is mainly due to an aging population, as advancing age raises the risk of genetic mutations and immune system dysfunction that contribute to the condition. Injectable cytotoxic drugs treat rheumatoid arthritis by targeting rapidly dividing cells and suppressing overactive immune responses, thereby slowing disease progression and alleviating symptoms. For example, in June 2024, the Australian Institute of Health and Welfare, an independent statutory agency, reported that rheumatoid arthritis caused 1,322 deaths, equating to 5.1 deaths per 100,000 people, and accounted for 0.7% of all deaths in 2022. It contributed to 2.0% of the overall disease burden and represented 16% of the total burden from all musculoskeletal conditions in 2023. Therefore, the growing incidence of rheumatoid arthritis is fueling the expansion of the injectable cytotoxic drugs market.

Key players in the injectable cytotoxic drugs market are concentrating on securing regulatory approvals to broaden their product lines and speed up market entry. Regulatory approvals are formal authorizations granted by health authorities confirming that a drug meets required safety, efficacy, and quality standards before marketing and prescription. For instance, in March 2024, Astellas Pharma Inc., a pharmaceutical company based in Japan, received approval from Japan's Ministry of Health, Labour, and Welfare (MHLW) for VYLOY (zolbetuximab) to treat CLDN18.2-positive, unresectable, advanced, or recurrent gastric cancer. This approval was supported by Phase III clinical trials (SPOTLIGHT and GLOW) showing that VYLOY combined with chemotherapy significantly improves progression-free and overall survival. Patient eligibility is determined using a companion diagnostic test that detects CLDN18.2 expression in tumor cells. This therapy addresses a critical unmet need in gastric cancer, which is often diagnosed late and linked to poor prognosis worldwide.

In December 2023, Pfizer Inc., a US-based pharmaceutical company, acquired Seagen Inc. for an undisclosed amount. Through this acquisition, Pfizer aims to strengthen its leadership in oncology by leveraging Seagen's leading Antibody-Drug Conjugate (ADC) technology, an advanced form of targeted cytotoxic therapy, to expand its treatment portfolio and speed up the development of next-generation cancer therapies. Seagen Inc. is a US-based company specializing in the development and commercialization of antibody-drug conjugates (ADCs) for cancer treatment, including injectable cytotoxic drugs.

Major players in the injectable cytotoxic drugs market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Baxter International Inc., Fresenius Kabi AG, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Jazz Pharmaceuticals plc, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Ltd., Zydus Lifesciences Ltd., and NATCO Pharma Ltd.

North America was the largest region in the injectable cytotoxic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in injectable cytotoxic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the injectable cytotoxic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The injectable cytotoxic drugs market consists of sales of products, including topoisomerase inhibitors, taxanes, mitotic inhibitors, radiopharmaceutical cytotoxics, and targeted cytotoxic conjugates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Cytotoxic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable cytotoxic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable cytotoxic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable cytotoxic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Alkylating Agents; Antimetabolites; Plant Alkaloids; Antitumor Antibiotics; Platinum-Based Compounds; Cytotoxic Antibiotics; Other Drug Types
• 2) By Route Of Administration: Intravenous (IV); Intramuscular (IM); Subcutaneous (SC)
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Specialty Drug Stores
• 4) By Application: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Ovarian Cancer; Lymphoma; Leukemia; Other Applications
• 5) By End-User: Hospitals; Oncology Clinics; Ambulatory Surgical Centers; Research And Academic Institutes
• Subsegments:
• 1) By Alkylating Agents: Cyclophosphamide; Isocyanide; Melphalan; Busulfan
• 2) By Antimetabolites: Methotrexate; 5-Fluorouracil (5-FU); Cytarabine; Gemcitabine
• 3) By Plant Alkaloids: Vincristine; Vinblastine; Paclitaxel; Docetaxel
• 4) By Antitumor Antibiotics: Doxorubicin; Daunorubicin; Epirubicin; Bleomycin
• 5) By Platinum-Based Compounds: Cisplatin; Carboplatin; Oxaliplatin
• 6) By Cytotoxic Antibiotics: Mitomycin; Actinomycin D; Plicamycin
• 7) By Other Drug Types: Irinotecan; Etoposide; Denibulin; Trastuzumab Emtansine (ADC); Lutetium-177 Dotatate
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Sanofi S.A.; Bristol-Myers Squibb; Novartis AG; Eli Lilly and Company; Amgen Inc.; Merck KGaA; Baxter International Inc.; Fresenius Kabi AG; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Jazz Pharmaceuticals plc; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals plc; Amneal Pharmaceuticals Inc.; Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd.; NATCO Pharma Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Cytotoxic Drugs Market Characteristics

3. Injectable Cytotoxic Drugs Market Trends And Strategies

4. Injectable Cytotoxic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Injectable Cytotoxic Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Injectable Cytotoxic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Injectable Cytotoxic Drugs Market Growth Rate Analysis
• 5.4. Global Injectable Cytotoxic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Injectable Cytotoxic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Injectable Cytotoxic Drugs Total Addressable Market (TAM)

6. Injectable Cytotoxic Drugs Market Segmentation

• 6.1. Global Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Plant Alkaloids
• Antitumor Antibiotics
• Platinum-Based Compounds
• Cytotoxic Antibiotics
• Other Drug Types
• 6.2. Global Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
• 6.3. Global Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Specialty Drug Stores
• 6.4. Global Injectable Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Ovarian Cancer
• Lymphoma
• Leukaemia
• Other Applications
• 6.5. Global Injectable Cytotoxic Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Oncology Clinics
• Ambulatory Surgical Centres
• Research And Academic Institutes
• 6.6. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Alkylating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cyclophosphamide
• Ifosfamide
• Melphalan
• Busulfan
• 6.7. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Antimetabolites, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methotrexate
• 5-Fluorouracil (5-FU)
• Cytarabine
• Gemcitabine
• 6.8. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Plant Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vincristine
• Vinblastine
• Paclitaxel
• Docetaxel
• 6.9. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Antitumor Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Doxorubicin
• Daunorubicin
• Epirubicin
• Bleomycin
• 6.10. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Platinum-Based Compounds, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cisplatin
• Carboplatin
• Oxaliplatin
• 6.11. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Cytotoxic Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mitomycin
• Actinomycin D
• Plicamycin
• 6.12. Global Injectable Cytotoxic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Irinotecan
• Etoposide
• Eribulin
• Trastuzumab Emtansine (ADC)
• Lutetium-177 Dotatate

7. Injectable Cytotoxic Drugs Market Regional And Country Analysis

• 7.1. Global Injectable Cytotoxic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Injectable Cytotoxic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Injectable Cytotoxic Drugs Market

• 8.1. Asia-Pacific Injectable Cytotoxic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Injectable Cytotoxic Drugs Market

• 9.1. China Injectable Cytotoxic Drugs Market Overview
• 9.2. China Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Injectable Cytotoxic Drugs Market

• 10.1. India Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Injectable Cytotoxic Drugs Market

• 11.1. Japan Injectable Cytotoxic Drugs Market Overview
• 11.2. Japan Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Injectable Cytotoxic Drugs Market

• 12.1. Australia Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Injectable Cytotoxic Drugs Market

• 13.1. Indonesia Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Injectable Cytotoxic Drugs Market

• 14.1. South Korea Injectable Cytotoxic Drugs Market Overview
• 14.2. South Korea Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Injectable Cytotoxic Drugs Market

• 15.1. Western Europe Injectable Cytotoxic Drugs Market Overview
• 15.2. Western Europe Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Injectable Cytotoxic Drugs Market

• 16.1. UK Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Injectable Cytotoxic Drugs Market

• 17.1. Germany Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Injectable Cytotoxic Drugs Market

• 18.1. France Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Injectable Cytotoxic Drugs Market

• 19.1. Italy Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Injectable Cytotoxic Drugs Market

• 20.1. Spain Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Injectable Cytotoxic Drugs Market

• 21.1. Eastern Europe Injectable Cytotoxic Drugs Market Overview
• 21.2. Eastern Europe Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Injectable Cytotoxic Drugs Market

• 22.1. Russia Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Injectable Cytotoxic Drugs Market

• 23.1. North America Injectable Cytotoxic Drugs Market Overview
• 23.2. North America Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Injectable Cytotoxic Drugs Market

• 24.1. USA Injectable Cytotoxic Drugs Market Overview
• 24.2. USA Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Injectable Cytotoxic Drugs Market

• 25.1. Canada Injectable Cytotoxic Drugs Market Overview
• 25.2. Canada Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Injectable Cytotoxic Drugs Market

• 26.1. South America Injectable Cytotoxic Drugs Market Overview
• 26.2. South America Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Injectable Cytotoxic Drugs Market

• 27.1. Brazil Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Injectable Cytotoxic Drugs Market

• 28.1. Middle East Injectable Cytotoxic Drugs Market Overview
• 28.2. Middle East Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Injectable Cytotoxic Drugs Market

• 29.1. Africa Injectable Cytotoxic Drugs Market Overview
• 29.2. Africa Injectable Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Injectable Cytotoxic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Injectable Cytotoxic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Injectable Cytotoxic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Injectable Cytotoxic Drugs Market Competitive Landscape
• 30.2. Injectable Cytotoxic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Injectable Cytotoxic Drugs Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Amgen Inc.
• 31.3. Merck KGaA
• 31.4. Baxter International Inc.
• 31.5. Fresenius Kabi AG
• 31.6. Eisai Co. Ltd.
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Apotex Inc.
• 31.9. Jazz Pharmaceuticals plc
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Hikma Pharmaceuticals plc
• 31.12. Amneal Pharmaceuticals Inc.
• 31.13. Zydus Lifesciences Ltd.
• 31.14. NATCO Pharma Ltd.
• 31.15. Accord Healthcare Ltd.

32. Global Injectable Cytotoxic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Injectable Cytotoxic Drugs Market

34. Recent Developments In The Injectable Cytotoxic Drugs Market

35. Injectable Cytotoxic Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Injectable Cytotoxic Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Injectable Cytotoxic Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Injectable Cytotoxic Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료